Menu
 

Search abstracts


Dose dependent pharmacokinetics of citalopram in humans

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: EMAMI, Jaber (Isfahan University of Medical Sciences, Isfahan, Iran)
  • Co-author(s): Ali-Mohammad, Sabzghabaee (Isfahan University of Medical Sciences, ISFAHAN, Iran)
    Hasan, Soleimani (Isfahan University of Medical Sciences, ISFAHAN, Iran)
    Ramezani, Razieh (Isfahan University of Medical Sciences, ISFAHAN, Iran)
  • Abstract:

    Introduction: Pharmacokinetics of citalopram have been well described after single doses of up to 60 mg (1). Administration of doses greater than 60 mg for resistant patients is routine (2). The objective of present study was, therefore, to investigate the pharmacokinetic behavior of citalopram after oral administration of single doses of 40 and..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses